Vaidyanathan, Deepika, Williams, Asher, Dordick, Jonathan S., Koffas, Mattheos A.G., and Linhardt, Robert J. Engineered heparins as new anticoagulant drugs: VAIDYANATHAN ET AL.. Bioengineering & Translational Medicine 2.1 Web. doi:10.1002/btm2.10042.

Vaidyanathan, Deepika, Williams, Asher, Dordick, Jonathan S., Koffas, Mattheos A.G., & Linhardt, Robert J. Engineered heparins as new anticoagulant drugs: VAIDYANATHAN ET AL.. Bioengineering & Translational Medicine, 2 (1). https://doi.org/10.1002/btm2.10042

Vaidyanathan, Deepika, Williams, Asher, Dordick, Jonathan S., Koffas, Mattheos A.G., and Linhardt, Robert J. "Engineered heparins as new anticoagulant drugs: VAIDYANATHAN ET AL.". Bioengineering & Translational Medicine 2 (1). Country unknown/Code not available: Wiley Blackwell (John Wiley & Sons). https://doi.org/10.1002/btm2.10042. https://par.nsf.gov/biblio/10024982.

@article{osti_10024982,
place = {Country unknown/Code not available}, title = {Engineered heparins as new anticoagulant drugs: VAIDYANATHAN ET AL.}, url = {https://par.nsf.gov/biblio/10024982}, DOI = {10.1002/btm2.10042}, abstractNote = {Not Available}, journal = {Bioengineering & Translational Medicine}, volume = {2}, number = {1}, publisher = {Wiley Blackwell (John Wiley & Sons)}, author = {Vaidyanathan, Deepika and Williams, Asher and Dordick, Jonathan S. and Koffas, Mattheos A.G. and Linhardt, Robert J.}, }